Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 16, 2021 - Issue
Submit an article Journal homepage
176
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Prescription Patterns in Patients with Chronic Obstructive Pulmonary Disease and Osteoporosis

Kuang-Ming Liao1 Department of Internal Medicine, Chi Mei Medical Center, Chiali, Taiwan, Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-4364-8248View further author information
ORCID Icon,
Kai-Lin Chiu2 Master Program in Clinical Pharmacy, School of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan, Republic of China;3 Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, Republic of ChinaView further author information
&
Chung-Yu Chen2 Master Program in Clinical Pharmacy, School of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan, Republic of China;3 Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, Republic of China;4 Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, Republic of China;5 Center for Big Data Research, Kaohsiung Medical University, Kaohsiung, TaiwanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7206-3957View further author information
ORCID Icon
Pages 761-769 | Published online: 25 Mar 2021

References

  • Andreassen H, Vestbo J. Chronic obstructive pulmonary disease as a systemic disease: an epidemiological perspective. Eur Respir J Suppl. 2003;46:2s–4s. doi:10.1183/09031936.03.00000203
  • Bolton CE, Ionescu AA, Shiels KM, et al. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170:1286–1293. doi:10.1164/rccm.200406-754OC
  • Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet. 2012;379(9823):1341–1351. doi:10.1016/S0140-6736(11)60968-9
  • Cielen N, Maes K, Gayan-Ramirez G. Musculoskeletal disorders in chronic obstructive pulmonary disease. Biomed Res Int. 2014;2014:965764. doi:10.1155/2014/965764
  • Inoue D, Watanabe R, Okazaki R. COPD and osteoporosis: links, risks, and treatment challenges. Int J Chron Obstruct Pulmon Dis. 2016;11:637–648. doi:10.2147/COPD.S79638
  • Akyea RK, McKeever TM, Gibson J, Scullion JE, Bolton CE. Predicting fracture risk in patients with chronic obstructive pulmonary disease: a UK-based population-based cohort study. BMJ Open. 2019;9:e024951. doi:10.1136/bmjopen-2018-024951
  • de Luise C, Brimacombe M, Pedersen L. Chronic obstructive pulmonary disease and mortality following hip fracture: a population-based cohort study. Eur J Epidemiol. 2008;23:115. doi:10.1007/s10654-007-9211-5
  • Bilezikian MD. Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis. Am J Med. 2009;122(2):S14–S21. doi:10.1016/j.amjmed.2008.12.003
  • Cesareo R, Lozzino M, D’onofrio L. Effectiveness and safety of calcium and vitamin D treatment for postmenopausal osteoporosis. Minerva Endocrinol. 2015;40(3):231–237.
  • Graat-Verboom L, Spruit MA, van den Borne BEEM, et al. Correlates of osteoporosis in chronic obstructive pulmonary disease: an underestimated systemic component. Respir Med. 2009;103:1143–1151. doi:10.1016/j.rmed.2009.02.014
  • Ferguson GT, Calverley PMA, Anderson JA, et al. Prevalence and progression of osteoporosis in patients with COPD. Chest. 2009;136:1456–1465. doi:10.1378/chest.08-3016
  • Brask-Lindemann D, Eiken P, Eskildsen P, Abrahamsen B. Time trends for alendronate prescription practices in women with chronic obstructive pulmonary disease and women exposed to systemic glucocorticoids. Osteoporos Int. 2013;24(6):1891–1897. doi:10.1007/s00198-012-2220-6
  • Graat-Verboom L, van den Borne BE, Smeenk FW, Spruit MA, Wouters EF. Osteoporosis in COPD outpatients based on bone mineral density and vertebral fractures. J Bone Miner Res. 2011;26(3):561–568. doi:10.1002/jbmr.257
  • Yamauchi Y, Yasunaga H, Sakamoto Y, et al. Mortality associated with bone fractures in COPD patients. Int J Chron Obstruct Pulmon Dis. 2016;11:2335–2340. doi:10.2147/COPD.S112142
  • Cha YH, Ha YC, Park HJ, et al. Relationship of chronic obstructive pulmonary disease severity with early and late mortality in elderly patients with hip fracture. Injury. 2019;50(9):1529–1533. doi:10.1016/j.injury.2019.05.021
  • Watanabe R, Tanaka T, Aita K, et al. Osteoporosis is highly prevalent in Japanese males with chronic obstructive pulmonary disease and is associated with deteriorated pulmonary function. J Bone Miner Metab. 2015;33(4):392–400. doi:10.1007/s00774-014-0605-7
  • Carter JD, Patel S, Sultan FL, et al. The recognition and treatment of vertebral fractures in males with chronic obstructive pulmonary disease. Respir Med. 2008;102(8):1165–1172. doi:10.1016/j.rmed.2008.03.003
  • Majumdar SR, Villa-Roel C, Lyons KJ, Rowe BH. Prevalence and predictors of vertebral fracture in patients with chronic obstructive pulmonary disease. Respir Med. 2010;104(2):260–266. doi:10.1016/j.rmed.2009.09.013
  • Green AR, Carrillo JE, Betancourt JR. Why the disease-based model of medicine fails our patients. West J Med. 2002;176(2):141–143.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.